Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients

Leonardo Potenza, Daniela Vallerini, Patrizia Barozzi, Giovanni Riva, Fabio Forghieri, Anne Beauvais, Remi Beau, Anna Candoni, Johan Maertens, Giulio Rossi, Monica Morselli, Eleonora Zanetti, Chiara Quadrelli, Mauro Codeluppi, Giovanni Guaraldi, Livio Pagano, Morena Caira, Cinzia Del Giovane, Monica Maccaferri, Alessandro StefaniUliano Morandi, Giovanni Tazzioli, Massimo Girardis, Mario Delia, Giorgina Specchia, Giuseppe Longo, Roberto Marasca, Franco Narni, Francesco Merli, Annalisa Imovilli, Giovanni Apolone, Agostinho Carvalho, Patrizia Comoli, Luigina Romani, Jean Paul Latgè, Mario Luppi

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Several studies in mouse model of invasive aspergillosis (IA) and in healthy donors have shown that different Aspergillus antigens may stimulate different adaptive immune responses. However, the occurrence of Aspergillus-specific T cells have not yet been reported in patients with the disease. In patients with IA, we have investigated during the infection: a) whether and how specific T-cell responses to different Aspergillus antigens occur and develop; b) which antigens elicit the highest frequencies of protective immune responses and, c) whether such protective T cells could be expanded ex-vivo. Forty hematologic patients have been studied, including 22 patients with IA and 18 controls. Specific T cells producing IL-10, IFN-γ, IL-4 and IL-17A have been characterized through enzyme linked immunospot and cytokine secretion assays on 88 peripheral blood (PB) samples, by using the following recombinant antigens: GEL1p, CRF1p, PEP1p, SOD1p, α1-3glucan, β1-3glucan, galactomannan. Specific T cells were expanded through short term culture. Aspergillus-specific T cells producing non-protective interleukin-10 (IL-10) and protective interferon-gamma (IFN-γ) have been detected to all the antigens only in IA patients. Lower numbers of specific T cells producing IL-4 and IL-17A have also been shown. Protective T cells targeted predominantly Aspergillus cell wall antigens, tended to increase during the IA course and to be associated with a better clinical outcome. Aspergillus-specific T cells could be successfully generated from the PB of 8 out of 8 patients with IA and included cytotoxic subsets able to lyse Aspergillus hyphae. Aspergillus specific T-cell responses contribute to the clearance of the pathogen in immunosuppressed patients with IA and Aspergillus cell wall antigens are those mainly targeted by protective immune responses. Cytotoxic specific T cells can be expanded from immunosuppressed patients even during the infection by using the above mentioned antigens. These findings may be exploited for immunotherapeutic purposes in patients with IA.

Original languageEnglish
Article numbere74326
JournalPLoS One
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 4 2013

Fingerprint

Aspergillosis
T-cells
aspergillosis
Aspergillus
T-lymphocytes
immune response
antigens
T-Lymphocytes
Antigens
Interleukin-17
interleukin-4
interleukin-10
interferon-gamma
Interleukin-4
Interleukin-10
Cell Wall
Interferon-gamma
Blood
Cells
cell walls

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients. / Potenza, Leonardo; Vallerini, Daniela; Barozzi, Patrizia; Riva, Giovanni; Forghieri, Fabio; Beauvais, Anne; Beau, Remi; Candoni, Anna; Maertens, Johan; Rossi, Giulio; Morselli, Monica; Zanetti, Eleonora; Quadrelli, Chiara; Codeluppi, Mauro; Guaraldi, Giovanni; Pagano, Livio; Caira, Morena; Del Giovane, Cinzia; Maccaferri, Monica; Stefani, Alessandro; Morandi, Uliano; Tazzioli, Giovanni; Girardis, Massimo; Delia, Mario; Specchia, Giorgina; Longo, Giuseppe; Marasca, Roberto; Narni, Franco; Merli, Francesco; Imovilli, Annalisa; Apolone, Giovanni; Carvalho, Agostinho; Comoli, Patrizia; Romani, Luigina; Latgè, Jean Paul; Luppi, Mario.

In: PLoS One, Vol. 8, No. 9, e74326, 04.09.2013.

Research output: Contribution to journalArticle

Potenza, L, Vallerini, D, Barozzi, P, Riva, G, Forghieri, F, Beauvais, A, Beau, R, Candoni, A, Maertens, J, Rossi, G, Morselli, M, Zanetti, E, Quadrelli, C, Codeluppi, M, Guaraldi, G, Pagano, L, Caira, M, Del Giovane, C, Maccaferri, M, Stefani, A, Morandi, U, Tazzioli, G, Girardis, M, Delia, M, Specchia, G, Longo, G, Marasca, R, Narni, F, Merli, F, Imovilli, A, Apolone, G, Carvalho, A, Comoli, P, Romani, L, Latgè, JP & Luppi, M 2013, 'Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients', PLoS One, vol. 8, no. 9, e74326. https://doi.org/10.1371/journal.pone.0074326
Potenza, Leonardo ; Vallerini, Daniela ; Barozzi, Patrizia ; Riva, Giovanni ; Forghieri, Fabio ; Beauvais, Anne ; Beau, Remi ; Candoni, Anna ; Maertens, Johan ; Rossi, Giulio ; Morselli, Monica ; Zanetti, Eleonora ; Quadrelli, Chiara ; Codeluppi, Mauro ; Guaraldi, Giovanni ; Pagano, Livio ; Caira, Morena ; Del Giovane, Cinzia ; Maccaferri, Monica ; Stefani, Alessandro ; Morandi, Uliano ; Tazzioli, Giovanni ; Girardis, Massimo ; Delia, Mario ; Specchia, Giorgina ; Longo, Giuseppe ; Marasca, Roberto ; Narni, Franco ; Merli, Francesco ; Imovilli, Annalisa ; Apolone, Giovanni ; Carvalho, Agostinho ; Comoli, Patrizia ; Romani, Luigina ; Latgè, Jean Paul ; Luppi, Mario. / Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients. In: PLoS One. 2013 ; Vol. 8, No. 9.
@article{440e2ff6fee24f1196ac1413485732bc,
title = "Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients",
abstract = "Several studies in mouse model of invasive aspergillosis (IA) and in healthy donors have shown that different Aspergillus antigens may stimulate different adaptive immune responses. However, the occurrence of Aspergillus-specific T cells have not yet been reported in patients with the disease. In patients with IA, we have investigated during the infection: a) whether and how specific T-cell responses to different Aspergillus antigens occur and develop; b) which antigens elicit the highest frequencies of protective immune responses and, c) whether such protective T cells could be expanded ex-vivo. Forty hematologic patients have been studied, including 22 patients with IA and 18 controls. Specific T cells producing IL-10, IFN-γ, IL-4 and IL-17A have been characterized through enzyme linked immunospot and cytokine secretion assays on 88 peripheral blood (PB) samples, by using the following recombinant antigens: GEL1p, CRF1p, PEP1p, SOD1p, α1-3glucan, β1-3glucan, galactomannan. Specific T cells were expanded through short term culture. Aspergillus-specific T cells producing non-protective interleukin-10 (IL-10) and protective interferon-gamma (IFN-γ) have been detected to all the antigens only in IA patients. Lower numbers of specific T cells producing IL-4 and IL-17A have also been shown. Protective T cells targeted predominantly Aspergillus cell wall antigens, tended to increase during the IA course and to be associated with a better clinical outcome. Aspergillus-specific T cells could be successfully generated from the PB of 8 out of 8 patients with IA and included cytotoxic subsets able to lyse Aspergillus hyphae. Aspergillus specific T-cell responses contribute to the clearance of the pathogen in immunosuppressed patients with IA and Aspergillus cell wall antigens are those mainly targeted by protective immune responses. Cytotoxic specific T cells can be expanded from immunosuppressed patients even during the infection by using the above mentioned antigens. These findings may be exploited for immunotherapeutic purposes in patients with IA.",
author = "Leonardo Potenza and Daniela Vallerini and Patrizia Barozzi and Giovanni Riva and Fabio Forghieri and Anne Beauvais and Remi Beau and Anna Candoni and Johan Maertens and Giulio Rossi and Monica Morselli and Eleonora Zanetti and Chiara Quadrelli and Mauro Codeluppi and Giovanni Guaraldi and Livio Pagano and Morena Caira and {Del Giovane}, Cinzia and Monica Maccaferri and Alessandro Stefani and Uliano Morandi and Giovanni Tazzioli and Massimo Girardis and Mario Delia and Giorgina Specchia and Giuseppe Longo and Roberto Marasca and Franco Narni and Francesco Merli and Annalisa Imovilli and Giovanni Apolone and Agostinho Carvalho and Patrizia Comoli and Luigina Romani and Latg{\`e}, {Jean Paul} and Mario Luppi",
year = "2013",
month = "9",
day = "4",
doi = "10.1371/journal.pone.0074326",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients

AU - Potenza, Leonardo

AU - Vallerini, Daniela

AU - Barozzi, Patrizia

AU - Riva, Giovanni

AU - Forghieri, Fabio

AU - Beauvais, Anne

AU - Beau, Remi

AU - Candoni, Anna

AU - Maertens, Johan

AU - Rossi, Giulio

AU - Morselli, Monica

AU - Zanetti, Eleonora

AU - Quadrelli, Chiara

AU - Codeluppi, Mauro

AU - Guaraldi, Giovanni

AU - Pagano, Livio

AU - Caira, Morena

AU - Del Giovane, Cinzia

AU - Maccaferri, Monica

AU - Stefani, Alessandro

AU - Morandi, Uliano

AU - Tazzioli, Giovanni

AU - Girardis, Massimo

AU - Delia, Mario

AU - Specchia, Giorgina

AU - Longo, Giuseppe

AU - Marasca, Roberto

AU - Narni, Franco

AU - Merli, Francesco

AU - Imovilli, Annalisa

AU - Apolone, Giovanni

AU - Carvalho, Agostinho

AU - Comoli, Patrizia

AU - Romani, Luigina

AU - Latgè, Jean Paul

AU - Luppi, Mario

PY - 2013/9/4

Y1 - 2013/9/4

N2 - Several studies in mouse model of invasive aspergillosis (IA) and in healthy donors have shown that different Aspergillus antigens may stimulate different adaptive immune responses. However, the occurrence of Aspergillus-specific T cells have not yet been reported in patients with the disease. In patients with IA, we have investigated during the infection: a) whether and how specific T-cell responses to different Aspergillus antigens occur and develop; b) which antigens elicit the highest frequencies of protective immune responses and, c) whether such protective T cells could be expanded ex-vivo. Forty hematologic patients have been studied, including 22 patients with IA and 18 controls. Specific T cells producing IL-10, IFN-γ, IL-4 and IL-17A have been characterized through enzyme linked immunospot and cytokine secretion assays on 88 peripheral blood (PB) samples, by using the following recombinant antigens: GEL1p, CRF1p, PEP1p, SOD1p, α1-3glucan, β1-3glucan, galactomannan. Specific T cells were expanded through short term culture. Aspergillus-specific T cells producing non-protective interleukin-10 (IL-10) and protective interferon-gamma (IFN-γ) have been detected to all the antigens only in IA patients. Lower numbers of specific T cells producing IL-4 and IL-17A have also been shown. Protective T cells targeted predominantly Aspergillus cell wall antigens, tended to increase during the IA course and to be associated with a better clinical outcome. Aspergillus-specific T cells could be successfully generated from the PB of 8 out of 8 patients with IA and included cytotoxic subsets able to lyse Aspergillus hyphae. Aspergillus specific T-cell responses contribute to the clearance of the pathogen in immunosuppressed patients with IA and Aspergillus cell wall antigens are those mainly targeted by protective immune responses. Cytotoxic specific T cells can be expanded from immunosuppressed patients even during the infection by using the above mentioned antigens. These findings may be exploited for immunotherapeutic purposes in patients with IA.

AB - Several studies in mouse model of invasive aspergillosis (IA) and in healthy donors have shown that different Aspergillus antigens may stimulate different adaptive immune responses. However, the occurrence of Aspergillus-specific T cells have not yet been reported in patients with the disease. In patients with IA, we have investigated during the infection: a) whether and how specific T-cell responses to different Aspergillus antigens occur and develop; b) which antigens elicit the highest frequencies of protective immune responses and, c) whether such protective T cells could be expanded ex-vivo. Forty hematologic patients have been studied, including 22 patients with IA and 18 controls. Specific T cells producing IL-10, IFN-γ, IL-4 and IL-17A have been characterized through enzyme linked immunospot and cytokine secretion assays on 88 peripheral blood (PB) samples, by using the following recombinant antigens: GEL1p, CRF1p, PEP1p, SOD1p, α1-3glucan, β1-3glucan, galactomannan. Specific T cells were expanded through short term culture. Aspergillus-specific T cells producing non-protective interleukin-10 (IL-10) and protective interferon-gamma (IFN-γ) have been detected to all the antigens only in IA patients. Lower numbers of specific T cells producing IL-4 and IL-17A have also been shown. Protective T cells targeted predominantly Aspergillus cell wall antigens, tended to increase during the IA course and to be associated with a better clinical outcome. Aspergillus-specific T cells could be successfully generated from the PB of 8 out of 8 patients with IA and included cytotoxic subsets able to lyse Aspergillus hyphae. Aspergillus specific T-cell responses contribute to the clearance of the pathogen in immunosuppressed patients with IA and Aspergillus cell wall antigens are those mainly targeted by protective immune responses. Cytotoxic specific T cells can be expanded from immunosuppressed patients even during the infection by using the above mentioned antigens. These findings may be exploited for immunotherapeutic purposes in patients with IA.

UR - http://www.scopus.com/inward/record.url?scp=84883371217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883371217&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0074326

DO - 10.1371/journal.pone.0074326

M3 - Article

C2 - 24023936

AN - SCOPUS:84883371217

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e74326

ER -